December 12, 2013
False Claims Act Legal News
Under the False Claims Act, companies must engage in honest, law-abiding behavior with regard to any aspect of healthcare to be reimbursed by federal entities like Medicare or Medicaid. For instance, pharmaceutical companies are required to adhere to the provisions of their FDA approvals when marketing drugs to physicians and […]
December 11, 2013
False Claims Act Legal News
The federal False Claims Act (“FCA”) is widely-touted as one of the most successful pieces of legislation in American history. Its success is rooted in the incentivization of integrity which, right or wrong, seems to work. To date, the FCA has been pivotal in the U.S. government recouping billions of […]
December 10, 2013
False Claims Act Legal News
Federal law prohibits private companies from engaging in fraudulent misconduct and misspending of federal funds. This includes all contractors doing business with the federal government or any entity receiving federal funds through a reimbursement program. One of the top sources of federal fraud arises in the healthcare industry and is […]
December 9, 2013
Military Contractor Fraud
While we regularly report on the impact of healthcare fraud, misspending of taxpayer dollars is far more rampant than faulty invoices to Medicare. In fact, fraud by government contractors can be pinpointed in nearly every area of government contract. Without the help of whistleblowers, this fraud would go unchecked for […]
December 6, 2013
False Claims Act Legal News
The Department of Health and Human Services has been under close scrutinization since the implementation of the Affordable Care Act and its accompanying internet portal healthcare.gov. Notwithstanding this unprecedented, unexpected public scrutiny, the HHS has published for public review a report of its goals and aspirations through 2018, which include […]
December 6, 2013
False Claims Act Legal News
All this week, we have been focusing on whistleblower protections as they pertain to the securities market. Whistleblowers with original information of trading, disclosure or other types of fraud are now able to make reports of misconduct under the new qui tam provisions of the Dodd-Frank Act, which was enacted […]
December 5, 2013
False Claims Act Legal News
Over the past several days, we have reviewed a recent report submitted to Congress by the Securities and Exchange Commission detailing its unveiling of the Office of Whistleblower Protection (OWB). The OWB was set up in response to the 2010 Dodd-Frank Act, which effectuated Wall Street reform and is designed […]
December 3, 2013
SEC Fraud
In yesterday’s post, we introduced and began reviewing the recent report submitted to Congress by the SEC. It provides helpful details and insight into the whistleblower program advanced by the Dodd Frank Act as well as an analysis of fiscal year 2013 and the highlights therein, including a record-breaking $14 […]
December 2, 2013
SEC Fraud
As we reported last week, the Dodd-Frank Wall Street Reform and Consumer Protection Act has been highly integral in protecting investors and taxpayers as well as holding fraudulent investors and corporate managers responsible for their misdeeds. Earlier this month, the Securities Exchange Commission, an entity responsible for overseeing the securities […]
November 29, 2013
False Claims Act Information
Our blog often discusses litigation surrounding the False Claims Act, which is the hallmark whistleblower statute in the United States. Enacted during the Civil War, the FCA and its incentivizing qui tam provisions paved the way for other government entities to advocate for Congress to enact similar provisions in their […]
November 28, 2013
False Claims Act Legal News
According to the Department of Health and Human Services, the federal anti-kickback statute serves one purpose: to protect patients and the federal health care programs from fraud and abuse by curtailing the corrupting influence of money on health care decisions. As we have reported in the past, this law has proven […]
November 27, 2013
False Claims Act Legal News
In yet another case of unlawful Medicare billing, Vantage Oncology Center has agreed to pay $2 million to settle allegations it defrauded federal healthcare entities including Medicare and Medicaid. This case comes on the heels of a recent mega-settlement by neighbor Omnicare, Inc., a pharmacy services company alleged to have […]